The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer therapeutics market was valued at USD 13.23 ...

IPA's strategy melds AI-driven analytics with specialised wet-lab methodologies to design and optimise antibodies.

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation HONG KONG, Mar 7, 2025 - (ACN Newswire) - </strong ...

Research into miRNA-mRNA interactions initially suggested a ... may play a role in generating diversity and variability in mRNA sequences related to the disease. Having confirmed that significant ...

Given the growing antibiotic resistance crisis, novel ways to target bacterial infections are becoming increasingly important. One potential strategy is to manipulate bacterial genes at the ...

The author is looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing.

This film creatively illustrates the process of protein synthesis through dance, symbolizing the assembly of amino acids into proteins. It explains how genes encode instructions for amino acid ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...

The collaboration leverages RIBOPRO’s expertise in mRNA sequence optimization and LNP-based delivery with IPA’s advanced B-cell screening, single-cell analysis, and deep-learning AI-driven ...